Table 3.
Duration of baseline multivitamin use and risk of hypertension.
| No use (n=17,398) |
<10 years (n=7210) |
≥10 years (n=1690) |
|
|---|---|---|---|
| Cases | 10,084 | 4176 | 1690 |
| Age-adjusted HR (95% CI) | 1.00 (ref) | 1.01 (0.98, 1.05) | 0.96 (0.91, 1.01) |
| + Lifestyle factorsa | 1.00 (ref) | 1.04 (1.00, 1.07) | 1.02 (0.96, 1.07) |
| + Lifestyle, clinical, dietary factorsb |
1.00 (ref) | 1.04 (1.00, 1.08) | 1.02 (0.97, 1.07) |
HR, hazard ratio; CI, confidence interval. All statistical tests were conducted by using Cox proportional hazards regression models.
a
Additionally adjusted for body mass index, smoking, physical activity, postmenopausal status, randomized treatment assignment, diabetes history, hypercholesterolemia history, alcohol consumption
b
Additionally adjusted for intakes of fruits and vegetables, and whole grains.